Browse > Article
http://dx.doi.org/10.4014/jmb.1502.02006

Enhanced Production of Epothilone by Immobilized Sorangium cellulosum in Porous Ceramics  

Gong, Guo-Li (School of Food and Biological Engineering, Shaanxi University of Science and Technology)
Huang, Yu-Ying (School of Food and Biological Engineering, Shaanxi University of Science and Technology)
Liu, Li-Li (School of Food and Biological Engineering, Shaanxi University of Science and Technology)
Chen, Xue-Feng (School of Food and Biological Engineering, Shaanxi University of Science and Technology)
Liu, Huan (School of Food and Biological Engineering, Shaanxi University of Science and Technology)
Publication Information
Journal of Microbiology and Biotechnology / v.25, no.10, 2015 , pp. 1653-1659 More about this Journal
Abstract
Epothilone, which is produced by the myxobacterium Sorangium cellulosum, contributes significant value in medicinal development. However, under submerged culture conditions, S. cellulosum will accumulate to form bacterial clumps, which hinder nutrient and metabolite transportation. Therefore, the production of epothilone by liquid fermentation is limited. In this study, diatomite-based porous ceramics were made from diatomite, paraffin, and poremaking agent (saw dust). Appropriate methods to modify the porous ceramics were also identified. After optimizing the preparation and modification conditions, we determined the optimal prescription to prepare high-performance porous ceramics. The structure of porous ceramics can provide a solid surface area where S. cellulosum can grow and metabolize to prevent the formation of bacterial clumps. S. cellulosum cells that do not form clumps will change their erratic metabolic behavior under submerged culture conditions. As a result, the unstable production of epothilone by this strain can be changed in the fermentation process, and the purpose of increasing epothilone production can be achieved. After 8 days of fermentation under optimized conditions, the epothilone yield reached 90.2 mg/l, which was increased four times compared with the fermentation without porous ceramics.
Keywords
Sorangium cellulosum; epothilone; porous ceramics; immobilization; fermentation condition;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Zhang XB, Meng GY, Ren XJ, Liu XQ. 2007. Preparation and characterization of porous cordierte ceramics from fly ash. J. Coal Sci. Eng. 34: 247-251.
2 Gong GL, Chen S, Li Hui, Zeng Q, Li N, Song JN. 2013. Genome shuffling improving the production of epothilone B. Chin. J. Antibiot. 38: 106-110.
3 Regentin R, Frykman S, Tsuruta H, Licari P. 2003. Nutrient regulation of epothilone biosynthesis in heterologous and native production. Appl. Microbiol. Biotechnol. 61: 451-455.   DOI
4 Diez J, Martinez JP, Mestres J, Sasse F, Frank R, Meyerhans A. 2012. Myxobacteria: natural pharmaceutical factories. Microb. Cell Fact. 11: 52-54.   DOI
5 Berengut D. 2006. Statisties for experiments: design, innovation, and discovery. Am. Stat. 60: 341-342.   DOI
6 Davies J, Ryan KS. 2012. Introducing the parvome: bioactive compounds in the microbial world. ACS Chem. Biol. 7: 252-259.   DOI
7 Devi S, Sridhar P. 1999. Optimization of critical parameters for immobilization of Streptomyces clavuligerus on alginate gel matrix for cephamycin C production. World J. Microbiol. Biotechnol. 15: 185-192.   DOI
8 Duarte JC, Rodrigues JA, Moran PJ, Valença GP, Nunhez JR. 2013. Effect of immobilized cells in calcium alginate beads in alcoholic fermentation. AMB Express 3: 31.   DOI
9 Forli S. 2014. Epothilones: from discovery to clinical trials. Curr. Top Med. Chem. 14: 2312-2321.   DOI
10 Gerth K, Bedorf N, Hofle G, Irschik H, Reichenbach H. 1996. Epothilone A and B: antifungal and cytotoxic compounds from Sorangium cellusosum (Myxobacteria). J. Antibiot. 49: 560-563.   DOI
11 Gong GL, Liu LL, Wang N. 2013. Preparation of diatomitebased porous ceramics for adsorbing and fixing Sorangium cellulosum. Modern Chem. Ind. 33: 66-70.
12 Almeida C, Brányik T, Moradas-Ferreira P, Teixeira J. 2004. Use of two different carriers in a packed bed reactor for endopolygalacturonase production by a yeast strain. Process Biochem. 40: 1937-1942.   DOI
13 Li YZ, Gong GL, Sun X, Liu XL, Hu W, Cao WR, et al. 2007. Mutation and a high-throughput screening method for improving the production of epothilone of Soragium. J. Ind. Microbiol. Biotechnol. 34: 615-623.   DOI
14 Gong GL, Zhao TF, Li H. 2014. Preparation and adsorption properties of mixed-templates molecularly imprinted polymers of epothilone B. J. Chem. Pharm. Res. 6: 1421-1427.
15 Julieb B, Shas S. 2002. Heterologous expression of epothilone biosynthesis genes in Myxococcus xanthus. Antimicrob. Agents Chemother. 46: 2772-2778.   DOI
16 Lau J, Frykman S, Regentin R, Ou S, Turuta H, Licari P. 2002. Optimizing the heterologous production of epothilone D in Myxococcus xanthus. Biotechnol. Bioeng. 78: 280-286.   DOI
17 Li ZF, Zhao JY, Xia ZJ, Shi J, Liu H, Wu ZH, et al. 2007. Evolutionary diversity of ketoacyl synthases in cellulolytic myxobacterium Sorangium. Syst. Appl. Microbiol. 30: 189-196.   DOI
18 Manikandan R, Prabhu HJ, Sivshnmug P. 2007. Studies on degradation of chlorinated aromatic hydrocarbon by using immobilized cell crude extract of Pseudomonas aeruginosa. Afr. J. Biotechnol. 6: 1338-1342.
19 Noworyta A, Bryjak J. 1993. Process of penicillin G hydrolysis catalyzed by penicillin acylase immobilized on acylic carrier. Bioproc. Eng. 9: 271-275.   DOI
20 McMeen CR, Benjamin MM. 1997. NOM removal by slow sand filtration through iron oxide-coated olivine. J. Am. Water Works Assoc. 89: 57-71.   DOI
21 Abbott SL, Connor JO, Robin T, Zimmer BL, Janda JM. 2003. Biochemical properties of a newly described Escherichia species, Escherichia albertii. J. Clin. Microbiol. 41: 4852-4854.   DOI
22 Reichenbach H, Dworkin M. 1992. The Myxobacteria, pp. 3416-3487. In Balows A, Truper GH, Dworkin M, Harder W, Schleifer KH (eds.). The Prokaryotes, Vol 2. Springer, New York.
23 Rivera E, Lee J, Davies A. 2008. Clinical development of ixabepilone and other epothilone in patients with advanced solid tumors. Oncologist 13: 1207-1223.   DOI
24 Roche H, Yelle L, Cognetti F, Mauriac L, Bunnel C, Sparano J, et al. 2007. Phase clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy. J. Clin. Oncol. 25: 3415-3420.   DOI
25 Sim SJ, Park SW, Han SJ, Kim DS. 2007. Improvement of epothilone B production by in situ removal of ammonium using cation exchange resin in Sorangium cellulosum culture. Biochem. Eng. J. 37: 328-331.   DOI
26 Sim SJ, Park SW, Park SJ, Han SJ, Lee JW, Kim DS, et al. 2007. Repeated batch production of epothilone B by immobilized Sorangium cellulosum. J. Microbiol. Biotechnol. 17: 1208-1212.
27 Veelken M, Pape H. 1982. Production of tylosin and nikkomycin by immobilized Streptomyces cells. Appl. Microbiol. Biotechnol. 15: 206-210.   DOI